Ae Wealth Management LLC Amgen Inc Transaction History

Ae Wealth Management LLC

  • $9.76 Billion
  • Q3 2024

A detailed history of Ae Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Ae Wealth Management LLC holds 62,409 shares of AMGN stock, worth $16.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
62,409
Previous 19,241 224.35%
Holding current value
$16.2 Million
Previous $6.01 Million 234.52%
% of portfolio
0.21%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$309.38 - $337.38 $13.4 Million - $14.6 Million
43,168 Added 224.35%
62,409 $20.1 Million
Q2 2024

Aug 12, 2024
BUY
$262.75 - $319.31 $1.26 Million - $1.53 Million
4,789 Added 33.14%
19,241 $6.01 Million
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $18.6 Million - $22.5 Million
-69,216 Reduced 82.73%
14,452 $4.11 Million
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $530,321 - $598,266
2,074 Added 2.54%
83,668 $24.1 Million
Q3 2023

Oct 11, 2023
SELL
$218.65 - $271.46 $209,466 - $260,058
-958 Reduced 1.16%
81,594 $21.9 Million
Q2 2023

Jul 10, 2023
SELL
$214.27 - $253.37 $2.8 Million - $3.32 Million
-13,086 Reduced 13.68%
82,552 $18.3 Million
Q1 2023

Apr 14, 2023
BUY
$225.79 - $275.2 $2.68 Million - $3.26 Million
11,850 Added 14.14%
95,638 $23.1 Million
Q4 2022

Jan 31, 2023
BUY
$229.03 - $291.01 $2.06 Million - $2.61 Million
8,981 Added 12.01%
83,788 $22 Million
Q3 2022

Oct 25, 2022
BUY
$224.46 - $253.15 $194,382 - $219,227
866 Added 1.17%
74,807 $16.9 Million
Q2 2022

Aug 03, 2022
BUY
$230.71 - $256.74 $4.82 Million - $5.36 Million
20,879 Added 39.35%
73,941 $18 Million
Q1 2022

Apr 18, 2022
BUY
$219.27 - $242.57 $924,003 - $1.02 Million
4,214 Added 8.63%
53,062 $12.8 Million
Q4 2021

Jan 20, 2022
BUY
$198.88 - $227.6 $1.58 Million - $1.81 Million
7,964 Added 19.48%
48,848 $11 Million
Q3 2021

Nov 01, 2021
BUY
$212.27 - $248.7 $1.29 Million - $1.52 Million
6,094 Added 17.52%
40,884 $8.69 Million
Q2 2021

Jul 21, 2021
BUY
$233.58 - $259.14 $814,026 - $903,102
3,485 Added 11.13%
34,790 $8.48 Million
Q1 2021

Apr 27, 2021
SELL
$221.91 - $258.6 $1.44 Million - $1.68 Million
-6,495 Reduced 17.18%
31,305 $7.79 Million
Q4 2020

Feb 01, 2021
BUY
$216.38 - $257.67 $48,685 - $57,975
225 Added 0.6%
37,800 $8.69 Million
Q3 2020

Nov 06, 2020
BUY
$234.65 - $260.95 $1.75 Million - $1.95 Million
7,468 Added 24.8%
37,575 $9.55 Million
Q2 2020

Aug 05, 2020
BUY
$197.81 - $242.74 $185,941 - $228,175
940 Added 3.22%
30,107 $7.1 Million
Q1 2020

May 07, 2020
BUY
$182.24 - $241.7 $695,427 - $922,327
3,816 Added 15.05%
29,167 $5.91 Million
Q4 2019

Jan 15, 2020
BUY
$189.21 - $243.2 $268,488 - $345,100
1,419 Added 5.93%
25,351 $6.11 Million
Q3 2019

Nov 05, 2019
BUY
$174.11 - $208.62 $162,966 - $195,268
936 Added 4.07%
23,932 $4.63 Million
Q2 2019

Jul 22, 2019
BUY
$166.7 - $195.41 $2.7 Million - $3.17 Million
16,226 Added 239.68%
22,996 $4.24 Million
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $606,999 - $684,221
3,356 Added 98.3%
6,770 $1.29 Million
Q4 2018

Feb 15, 2019
SELL
$178.4 - $208.25 $783,711 - $914,842
-4,393 Reduced 56.27%
3,414 $665,000
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $602,748 - $679,519
3,253 Added 71.43%
7,807 $1.62 Million
Q2 2018

Aug 15, 2018
BUY
$166.05 - $186.51 $109,593 - $123,096
660 Added 16.95%
4,554 $841,000
Q1 2018

May 14, 2018
BUY
$169.43 - $198.0 $111,823 - $130,680
660 Added 20.41%
3,894 $664,000
Q4 2017

Feb 06, 2018
BUY
$168.79 - $188.59 $146,509 - $163,696
868 Added 36.69%
3,234 $562,000
Q3 2017

Nov 08, 2017
BUY
$167.29 - $191.0 $72,771 - $83,085
435 Added 22.53%
2,366 $441,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,931
1,931 $333,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email